Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

FRESENIUS SE : Barclays reiterates its Buy rating

10/21/2020 | 03:10am EST

Already positive, the research from Barclays and its analyst Hassan Al-Wakeel still consider the stock as a Buy opportunity. The target price differs slightly and is now set at EUR 54 versus EUR 55.


© MarketScreener with dpa-AFX Analyser 2020
Stocks mentioned in the article
ChangeLast1st jan.
BARCLAYS PLC 6.16% 143.32 Delayed Quote.-20.26%
FRESENIUS MEDICAL CARE AG & CO. KGAA 0.37% 70.76 Delayed Quote.7.28%
FRESENIUS SE & CO. KGAA 1.76% 38.16 Delayed Quote.-23.95%
All news about FRESENIUS SE & CO. KGAA
10:21aFRESENIUS : Kabi launches its first specialty IV drug in the U.S.
PU
07:50aFRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by ..
EQ
11/27Swiss drugmaker Vifor had bid interest but talks halted - sources
RE
11/26FRESENIUS SE : DZ Bank keeps its Buy rating
MD
11/24FRESENIUS SE : UBS remains Neutral
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : RBC reiterates its Neutral rating
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : Bernstein reiterates its Neutral rating
MD
11/19FRESENIUS SE : Bernstein reiterates its Buy rating
MD
11/19FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of quarter..
EQ
11/19FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of financi..
EQ
More news
Financials
Sales 2020 36 301 M 43 848 M 43 848 M
Net income 2020 1 790 M 2 162 M 2 162 M
Net Debt 2020 24 198 M 29 229 M 29 229 M
P/E ratio 2020 12,0x
Yield 2020 2,09%
Capitalization 21 273 M 25 643 M 25 696 M
EV / Sales 2020 1,25x
EV / Sales 2021 1,12x
Nbr of Employees 309 114
Free-Float 72,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 49,67 €
Last Close Price 38,16 €
Spread / Highest target 78,2%
Spread / Average Target 30,2%
Spread / Lowest Target -53,7%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA-23.95%24 985
AIER EYE HOSPITAL GROUP CO., LTD.101.11%38 350
IHH HEALTHCARE2.74%12 108
BANGKOK DUSIT MEDICAL SERVICES0.00%11 283
RAMSAY HEALTH CARE LIMITED-13.07%10 550
TOPCHOICE MEDICAL CORPORATION104.52%10 222